Severe congenital ichthyosis of the neonate

International Journal of Dermatology

Volumn 37, Issue 10, 1998, Pages 722-728

  Akiyama, Masashi ^a  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; GENETIC COUNSELING; HUMAN; HYPERKERATOSIS; LAMELLAR ICHTHYOSIS; LIPIDOSIS; NUTRITION; ONSET AGE; PROGNOSIS; REVIEW; SJOEGREN LARSSON SYNDROME;

HUMANS; ICHTHYOSIS; INFANT, NEWBORN; SKIN;

EID: 0031695220     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00488.x     Document Type: Review

References (67)

1. Williams MLK, Lynch PJ. Generalized disorders of cornification: the ichthyoses. In: Sams WM, Lynch PJ, eds. Principles and Practice of Dermatology. New York, NY: Churchill Livingstone, 1996: 379-396.
2. Judge MR, Harper JI. The ichthyoses. In: Harper J, ed. Inherited Skin Disorders: The Genodermatoses. Oxford: Butterworth-Heinemann, 1996: 69-96.
3. Suzumori K, Kanzaki T. Prenatal diagnosis of harlequin ichthyosis by fetal skin biopsy; report of two cases. Prenat Diagn 1991; 11: 451-457.
4. Dale BA, Kam E. Harlequin ichthyosis. Variability in expression and hypothesis for disease mechanism. Arch Dermatol 1993; 129: 1471-1477.
5. Williams ML, Elias PM. Genetically transmitted, generalized disorders of cornification; the ichthyoses. Dermatol Clin 1987; 5: 155-178.
6. Akiyama M, Holbrook KA. Analysis of skin-derived amniotic fluid cells in the second trimester; detection of severe genodermatoses expressed in the fetal period. J Invest Dermatol 1994; 103: 674-677.
7. Akiyama M, Kim D-K, Main DM, et al. Characteristic morphologic abnormality of harlequin ichthyosis detected in amniotic fluid cells. J Invest Dermatol 1994; 102: 210-213.
8. Dale BA, Holbrook KA, Fleckman P, et al. Heterogeneity in harlequin ichthyosis, an inborn error of epidermal keratinization: variable morphology and structural protein expression and a defect in lamellar granules. J Invest Dermatol 1990; 94: 6-18.
9. Milner ME, O'Guin WM, Holbrook KA, Dale BA. Abnormal lamellar granules in harlequin ichthyosis. J Invest Dermatol 1992; 99: 824-829.
10. Hashimoto K, Khan S. Harlequin fetus with abnormal lamellar granules and giant mitochondria. J Cutan Pathol 1992; 19: 247-252.
11. Hashimoto K, De Dobbeleer G, Kanzaki T. Electron microscopic studies of harlequin fetuses. Pediatr Dermatol 1993; 10: 214-223.
12. Akiyama M, Dale BA, Smith LT, et al. Regional difference in expression of characteristic abnormality of harlequin ichthyosis in affected fetuses. Prenat Diagn 1998; 18: 425-436.
13. Fleckman P, Hager B, Dale BA. Harlequin ichthyosis keratinocytes in lifted culture differentiate poorly by morphologic and biochemical criteria. J Invest Dermatol 1997; 109: 36-38.
14. Lawlor F, Peiris S. Harlequin fetus successfully treated with etretinate. Br J Dermatol 1985; 112: 585-590.
15. Lawlor F. Progress of a harlequin fetus to nonbullous ichthyosiform erythroderma. Pediatrics 1988; 82: 870-873.
16. Rogers M, Scraf C. Harlequin baby treated with etretinate. Pediatr Dermatol 1989; 6: 216-221.
17. Roberts LJ. Long-term survival of a harlequin fetus. J Am Acad Dermatol 1989; 21: 335-339.
18. Ward PS, Jones RD. Successful treatment of a harlequin fetus. Arch Dis Child 1989; 64: 1309-1311.
19. Prasad RS, Pejaver RK, Hassan A, et al. Management and follow-up of harlequin siblings. Br J Dermatol 1994; 130: 650-653.
20. Haftek M, Cambazard F, Dhouailly D, et al. A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. Br J Dermatol 1996; 135: 448-453.
21. Akiyama M, Yoneda K, Kim S-Y, et al. Cornified cell envelope proteins and keratins are normally distributed in harlequin ichthyosis. J Cutan Pathol 1996; 23: 571-575
22. Niemi K-M, Kanerva L, Kuokkamen K. Recessive ichthyosis congenita type II. Arch Dermatol Res 1991; 283: 211-218.
23. Ghadially R, Williams ML, Hou SYE, Elias PM. Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol 1992; 99: 755-763.
24. Hohl D, Huber M, Frenk E. Analysis of the cornified cell envelope in lamellar ichthyosis. Arch Dermatol 1993; 129: 618-624.
25. Akiyama M, Kim S-Y, Yoneda K, Shimizu H. Expression of transglutaminase 1 (transglutaminase K) in harlequin ichthyosis. Arch Dermatol Res 1997; 289: 116-119.
26. Williams ML, Elias PM. Heterogeneity in autosomal recessive ichthyosis. Arch Dermatol 1985; 121: 477-488.
27. Traupe H, Kolde G, Happle R. Autosomal dominant lamellar ichthyosis: a new skin disorder. Clin Genet 1984; 26: 457-461.
28. Toribio J, Redondo VF, Peteiro C, et al. Autosomal dominant lamellar ichthyosis. Clin Genet 1986; 30: 122-126.
29. Huber M, Rettler I, Bernasconi K, et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995; 267: 525-528.
30. Russell LJ, DiGiovanna JJ, Rogers GR, et al. Mutations in the gene for transglutaminase 1 in autosomal dominant lamellar ichthyosis. Nature Genet 1995; 9: 279-283.
31. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzyme that stabilizes tissues. FASEB J 1991; 5: 3071-3077.
32. Huber M, Rettler I, Bernasconi K, et al. Lamellar ichthyosis is genetically heterogeneous - cases with normal keratinocyte transglutaminase. J Invest Dermatol 1995; 105: 653-654.
33. Fuchs E. Genetic skin disorders of keratin. J Invest Dermatol 1992; 99: 671-674.
34. Leigh IM, Lane EB. Mutations in the genes for epidermal keratins in epidermolysis bullosa and epidermolytic hyperkeratosis. Arch Dermatol 1993; 129: 1571-1577.
35. Holbrook KA, Dale BA, Sybert VP, Sagebiel RW. Epidermolytic hyperkeratosis: ultrastructure and biochemistry of skin and amniotic fluid cells from two affected fetuses and a newborn infant. J Invest Dermatol 1983; 80: 222-2.27.
36. Ishida-Yamamoto A, McGrath JA, Judge MR, et al. Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma). J Invest Dermatol 1992; 99: 19-26.
37. Goldsmith L. Look at the genes, see what's in the jeans. Arch Dermatol 1990; 126: 585.
38. Sjögren T, Larsson T. Oligophrenia in association with congenital ichthyosis and spastic disorders. Acta Psychiatr Scand 1957; 32(Suppl. 113): 1-112.
39. + oxidoreductase in cultured fibroblasts. J Clin Invest 1991; 88: 1643-1648.
40. De Laurenzi V, Rogers GR, Hamrock DJ, et al. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nature Genet 1996; 12: 51-57.
41. Netherton EW. A unique case of trichorrhexis nodosa, 'Bamboo hairs'. Arch Dermatol 1958; 78: 483-487.
42. Greene SL, Muller SA. Netherton's syndrome: a report of a case and review of the literature. J Am Acad Dermatol 1985; 13: 329-337.
43. Ito M, Ho K, Hashimoto K. Pathogenesis of trichorrhexis invaginata {Bamboo hair). J Invest Dermatol 1984; 81: 1-6.
44. Judge MR, Morgan G, Harper JI. A clinical and immunological study of Netherton's syndrome. Br J Dermatol 1994; 131: 615-621.
45. Montagutelli X, Hogan ME, Aubin G, et al. Lanceolate hair (lah): a recessive mouse mutation with alopecia and abnormal hair. J Invest Dermatol 1996; 107: 20-25.
46. Dorfman ML, Hershko C, Eisenberg S, Sagher F. Ichthyosiform dermatosis with systemic lipidosis. Arch Dermatol 1974; 110: 261-266.
47. Chanarin I, Patel A, Slavin G, et al. Neutral lipid storage disease, a new disorder of lipid metabolism. Br Med J 1975; i: 553-555.
48. Judge MR, Atherton DJA, Salvayre R, et al. Neutral lipid storage disease. Case report and lipid studies. Br J Dermatol 1995; 130: 507-510.
49. Elias PM, Williams ML. Neutral lipid storage disease with ichthyosis. Defective lamellar body contents and intracellular dispersion. Arch Dermatol 1985; 121: 1000-1008.
50. Hilaire N, Salvayre R, Thiers J-C, et al. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways. J Biol Chem 1995; 270: 27 027-27 034.
51. Bloom D, Goodfried MS. Lamellar ichthyosis of the newborn. Arch Dermatol 1962; 86: 336-342.
52. Larrègue M, Gharbi R, Daniel J, et al. Le bébé collodion. Evolution à propos de 29 cas. Ann Dermatol Syphiligr 1976; 103: 31-56.
53. Frenk E, Mevorah B. The keratinization disorder in collodion babies evolving into lamellar ichthyosis. Its possible relevance for determining the primary defect in lamellar ichthyosis. J Cutan Pathol 1977; 4: 329-337.
54. Akiyama M Shimizu H, Yoneda K, Nishikawa T. Collodion baby: ultrastructure and distribution of cornified cell envelope proteins and keratins. Dermatology 1997; 195: 164-168.
55. Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Arch Dermatol 1995; 131: 556-560.
56. Lacour M, Mehta-Nikhar B, Atherton DJ, Harper JI. An appraisal of acitretin therapy in children with inherited disorders of keratinization. Br J Dermatol 1996; 134: 1023-1029.
57. Holbrook KA, Smith LT, Elias S. Prenatal diagnosis of genetic skin disease using fetal skin biopsy samples. Arch Dermatol 1993; 119: 1437-1454.
58. Christiane AM, Uitto J. DNA-based prenatal diagnosis of heritable skin diseases. Arch Dermatol 1993; 129: 1455-1459.
59. Blanchet-Bardon C, Dumez Y, Labbé F, et al. Prenatal diagnosis of harlequin fetus. Lancet 1983; i: 132.
60. Kousseff BG, Matsuoka LT, Stenn KS, et al. Prenatal diagnosis of Sjögren-Larsson syndrome. J Pediatr 1981; 101: 998-1001.
61. Tabsh K, Rizzo WB, Holbrook KA, Theroux N. Sjögren-Larsson syndrome: technique and timing of prenatal diagnosis. Obstet Gynecol 1993; 82: 700-703.
62. Rizzo WB, Craft DA, Kelson TL, et al. Prenatal diagnosis of Sjögren-Larsson syndrome using enzymatic methods. Prenat Diagn 1994; 14: 577-581.
63. Holbrook KA, Dale BA, Williams ML, et al. The expression of congenital ichthyosiform erythroderma in second trimester fetuses of the same family: morphologic and biochemical studies. J Invest Dermatol 1988; 91: 521-531.
64. Holbrook KA, Underwood RA, Dale BA, et al. Cornified cell envelope (CCE) in human fetal skin: involucrin, keratolinin, loricrin and transglutaminase expression and activity. J Invest Dermatol 1991; 96: 542.
65. Akiyama M, Smith LT, Yoneda K, et al. Expression of transglutaminase 1 (TG1) and cornified cell envelope (CCE) proteins during human epidermal development. J Invest Dermatol 1997; 108: 598.
66. Golbus MS, Sagebiel RW, Filly RA, et al. Prenatal diagnosis of congenital bullous ichthyosiform erythroderma (epidermolytic hyperkeratosis) by fetal skin biopsy. N Eng J Med 1980; 302: 93-95.
67. Rothnagel JA, Longley MA, Holder RA, et al. Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing. J Invest Dermatol 1994; 102: 13-16.